Stephanie Dell'aquila Stevens, Lcsw Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 88 Woodruff St, Saranac Lake, NY 12983 Phone: 518-637-5134 |
Adirondack Medical Center - Physician Psychologist - Prescribing (Medical) Medicare: Medicare Enrolled Practice Location: 2233 State Route 86, Saranac Lake, NY 12983 Phone: 518-891-4141 Fax: 518-897-2423 |
Adirondack Community Counseling Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 28 Bernard Street, Saranac Lake, NY 12983 Phone: 518-420-6023 |
St Josephs Addiction Treatment & Recovery Centers Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 159 Glenwood Dr, Saranac Lake, NY 12983 Phone: 518-891-3950 Fax: 518-891-6134 |
Adirondack Medical Center Hospital Units - Psychiatric Unit Medicare: Medicare Enrolled Practice Location: 2233 State Route 86, Colby Center, Saranac Lake, NY 12983 Phone: 518-897-2351 Fax: 518-897-2868 |
Michael Cochran Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 96 Clinton Ave Apt 2, Saranac Lake, NY 12983 Phone: 518-524-4955 |
News Archive
Scientists from Wake Forest University School of Medicine are the first to report that the stress hormone epinephrine causes changes in prostate and breast cancer cells that may make them resistant to cell death.
Stress affects most Americans at one point or another. Although some people are genetically more susceptible to the stressors of daily life than others, most could benefit from learning how to lower that stress before it negatively affects their physical and mental health.
A mother's perceived social status predicts her child's brain development and stress indicators, finds a study at Boston Children's Hospital. While previous studies going back to the 1950s have linked objective socioeconomic factors—such as parental income or education—to child health, achievement and brain function, the new study is the first to link brain function to maternal self-perception.
Results from a multinational phase II study presented today at the International Liver CongressTM 2010 have shown that treatment with the caspase inhibitor GS-9450 can reduce markers of liver damage in patients with non-alcoholic steatohepatitis (NASH - the most serious form of non-alcoholic liver disease) as demonstrated by reduced levels of alanine and aspartate aminotransferases, hepatic enzymes that indicate cell damage.
Early assessment of hemispheric and thalamic volumes in children with polymicrogyria and epilepsy can reliably predict the risk of continuous spike-and-wave complexes during sleep, a study indicates.
› Verified 1 days ago